FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
Breakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor
Source: kpvi.com
Targeting Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Targeting Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Targeting Therapy Today - Breaking & Trending Today
FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the...
Source: prnewswire.com
A little girl's legacy: Edenfield family's $150K donation creates new ACH fund | News, Sports, Jobs
Familyâs $150K donation creates new ACH fund Mar 15, 2021 A close-knit trio were Emilea, Melina and Klara Edenfield. After Melina lost her battle with a brain tumor, the two remaining sisters felt a void in their lives. Submitted photo CANFIELD — Melina Michelle Edenfield was an energetic 4-year-old Canfield girl who on May 22, 2020, was diagnosed with a deadly brain tumor. Her fight with diffuse midline glioma ended just 32 days later. While her battle was brief, her family wanted to make sure it wasn’t in vain, so the Melina Michelle Edenfield Foundation was established. It recen...
Source: vindy.com